Pfizer
Trade Pfizer 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About PFE
Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases.
PFE Key Statistics
Stock Snapshot
The current Pfizer(PFE) stock price is $25.34, with a market capitalization of 144.37B. The stock trades at a price-to-earnings (P/E) ratio of 19.42 and offers a dividend yield of 6.8%.
On 2026-05-16, Pfizer(PFE) stock traded between a low of $25.24 and a high of $25.87. Shares are currently priced at $25.34, which is +0.4% above the low and -2.0% below the high.
The Pfizer(PFE)'s current trading volume is 37.11M, compared to an average daily volume of 39.09M.
In the last year, Pfizer(PFE) shares hit a 52-week high of $28.75 and a 52-week low of $22.45.
In the last year, Pfizer(PFE) shares hit a 52-week high of $28.75 and a 52-week low of $22.45.
PFE News
Pfizer ( (PFE) ) has been popular among investors this week. Here is a recap of the key news on this stock. Claim 55% Off TipRanks Unlock hedge fund-level data...
Advertisement Pfizer stock snapshot and recent performance Pfizer (PFE) is back in focus for investors, with the stock closing at US$25.33 and showing mixed p...
Pfizer Inc (PFE) announced an update on their ongoing clinical study. Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions...
Analyst ratings
54%
of 28 ratingsMore PFE News
Michael Burry’s Latest Buys Include a 6.66% Yielding Pharma Giant and an Oil Stock Up 46% This Year. Here Is Why By Alex Sirois Published May 15, 9:49AM EDT Q...
Federal healthcare spending is projected to rise from less than $2 trillion today to more than $3 trillion within a decade, per the Committee for a Responsible...
Wolfe Research analyst Alexandria Hammond raised the firm’s price target on Pfizer (PFE) to $26 from $25 and keeps an Underperform rating on the shares followin...
Pfizer Inc (PFE) announced an update on their ongoing clinical study. Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions...
Pfizer Inc (PFE) announced an update on their ongoing clinical study. Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions...
Key Points The drugmaker is still nowhere near the heroic financial results it achieved at the height of the pandemic. In fact, it seems to be moving in the w...
European Commission expands approval for Pfizer's HYMPAVZI (marstacimab) to include adolescents and adults with hemophilia A or B and inhibitors. Decision addr...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.